- Home
- GPRO vs NTHI Comparison
GPRO vs NTHI Comparison
Compare GPRO & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- NTHI
- Stock Information
- Founded
- GPRO 2004
- NTHI 2008
- Country
- GPRO United States
- NTHI United States
- Employees
- GPRO N/A
- NTHI N/A
- Industry
- GPRO Industrial Machinery/Components
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- NTHI Health Care
- Exchange
- GPRO Nasdaq
- NTHI Nasdaq
- Market Cap
- GPRO 194.6M
- NTHI 229.0M
- IPO Year
- GPRO 2014
- NTHI N/A
- Fundamental
- Price
- GPRO $2.26
- NTHI $11.53
- Analyst Decision
- GPRO
- NTHI
- Analyst Count
- GPRO 0
- NTHI 0
- Target Price
- GPRO N/A
- NTHI N/A
- AVG Volume (30 Days)
- GPRO 13.5M
- NTHI 142.0K
- Earning Date
- GPRO 11-06-2025
- NTHI 11-19-2025
- Dividend Yield
- GPRO N/A
- NTHI N/A
- EPS Growth
- GPRO N/A
- NTHI N/A
- EPS
- GPRO N/A
- NTHI N/A
- Revenue
- GPRO $746,731,000.00
- NTHI $59,990.00
- Revenue This Year
- GPRO N/A
- NTHI N/A
- Revenue Next Year
- GPRO $9.72
- NTHI N/A
- P/E Ratio
- GPRO N/A
- NTHI N/A
- Revenue Growth
- GPRO N/A
- NTHI N/A
- 52 Week Low
- GPRO $0.40
- NTHI $3.20
- 52 Week High
- GPRO $3.05
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- GPRO 56.19
- NTHI N/A
- Support Level
- GPRO $2.04
- NTHI N/A
- Resistance Level
- GPRO $2.37
- NTHI N/A
- Average True Range (ATR)
- GPRO 0.29
- NTHI 0.00
- MACD
- GPRO -0.05
- NTHI 0.00
- Stochastic Oscillator
- GPRO 21.78
- NTHI 0.00
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).